Leading Investors Divest, Yet Stocks Continue to Rise: An Analysis

Ramit Sethi

Author of "I Will Teach You to Be Rich," focusing on psychology and systems for a rich life without guilt.

This article explores the intriguing market phenomenon where major institutional investors liquidate their positions in certain stocks, only for those same stocks to subsequently appreciate in value. It delves into the cases of Alphabet, Delta Air Lines, and Southwest Gas, which saw significant sell-offs by legendary investors, contrasting these moves with sustained positive analyst outlooks and robust market performance. The piece aims to provide clarity for retail investors navigating such mixed signals in the financial landscape.

Navigating the Market: When Giants Exit and Stocks Defy Expectations

Noteworthy Exits by Financial Titans

Three distinguished investors—Stanley Druckenmiller, David Tepper, and Carl Icahn—reduced their holdings in Alphabet (NASDAQ: GOOGL), Delta Air Lines (NYSE: DAL), and Southwest Gas (NYSE: SWX) during the first quarter of 2026, as revealed by their 13F filings. Despite these high-profile divestments, these companies' shares have continued to advance, challenging conventional market wisdom.

Discrepancy Between Investor Actions and Market Momentum

The market's reaction to these divestitures has been counterintuitive. Alphabet's stock, for instance, has gained over 20% since Druckenmiller's complete exit. Delta Air Lines, sold by Tepper at approximately $67, is now trading significantly higher. Similarly, Southwest Gas has seen an increase following Icahn's liquidation of his stake. This divergence prompts a closer look into why these stocks continue to perform well despite the departure of influential investors.

Examining Analyst Projections and Market Performance

Wall Street analysts maintain a strong bullish stance on all three companies. Alphabet boasts an average price target of $432.83, while Delta and Southwest Gas have targets of $82.97 and $99.25, respectively. These targets, coupled with the stocks' post-divestment gains—20.2% for Alphabet, 36.7% for Delta, and 2.9% for Southwest Gas—underscore a persistent confidence in their future prospects.

Underlying Financial Strength: A Closer Look at Fundamentals

The strong performance is backed by solid fundamentals. Alphabet reported a substantial earnings beat in Q1 2026, driven by impressive growth in Google Cloud revenue and a massive backlog. Delta Air Lines also showcased robust financial health with a significant year-over-year increase in adjusted EPS and optimistic guidance for the upcoming quarter. Southwest Gas reaffirmed its positive EPS outlook, projecting a healthy CAGR through 2030.

Alphabet: Balancing Innovation with Investment

Alphabet's bull case rests on its attractive forward P/E and high-profit margins, fueled by rapid AI monetization. However, a bear argument points to substantial capital expenditure guidance for 2026, which could impact free cash flow, and a significant portion of Q1 net income derived from unrealized equity gains.

Delta Air Lines: Growth Amidst Operational Challenges

For Delta, the bullish outlook is supported by its forward P/E, strong premium revenue growth, and substantial remuneration from American Express. Conversely, concerns arise from the stock trading near or above consensus targets, anticipated increases in fuel costs, and planned reductions in capacity growth.

Southwest Gas: Utility Stability Versus Market Valuation

Southwest Gas benefits from strong demand for its Great Basin pipeline and its classification as a regulated utility with an upgraded S&P rating. The bear case highlights a recent Q1 EPS miss, a relatively high trailing P/E for a utility, and delays in critical regulatory decisions.

Reconciling Smart Money Exits with Ongoing Market Optimism

The divestments by these seasoned investors, as reflected in their 13F filings, are typically backward-looking snapshots and often driven by portfolio rebalancing, risk management, or fund-specific strategies rather than a negative long-term view of the underlying businesses. For instance, Tepper secured profits from Delta, Icahn concluded an activist campaign at Southwest Gas, and Druckenmiller is known for his dynamic, concentrated bets. These actions are more indicative of individual portfolio decisions than a fundamental red flag for the companies themselves.

Investment Horizons: A Key Differentiator

The divergence between investor exits and analyst optimism often stems from differing time horizons. Hedge funds operate on quarterly cycles, managing short-term drawdown risks. In contrast, sell-side analysts typically provide 12-month fundamental outlooks. While Alphabet's target price still suggests considerable upside, Delta and Southwest Gas are trading closer to or above their consensus targets, implying a potentially reduced margin of safety for new investments compared to Alphabet.

Strategic Implications for Retail Investors

For retirement-focused investors, Alphabet continues to offer a clear fundamental growth path. However, for Delta Air Lines and Southwest Gas shareholders, the current valuations, hovering around or exceeding analyst targets, might signal a need for careful consideration. The key takeaway for retail investors is to understand that institutional divestments are not necessarily calls to sell but rather reflect complex portfolio management strategies. Evaluating a company's fundamentals and market position remains crucial for making informed investment decisions.

you may like

youmaylikeicon
Mirum Pharmaceuticals: A Potential Growth Story in Rare Diseases?

Mirum Pharmaceuticals: A Potential Growth Story in Rare Diseases?

By Bola Sokunbi
Upstream Bio: A Promising Biotech for Inflammatory Diseases

Upstream Bio: A Promising Biotech for Inflammatory Diseases

By Scott Pape
Bed Bath & Beyond's Strategic Initiatives: Coupon Hunt and Home Services Expansion

Bed Bath & Beyond's Strategic Initiatives: Coupon Hunt and Home Services Expansion

By Dave Ramsey
Edgewise Therapeutics Sees Price Target Boosted to $59 Following Positive HCM Trial Outcomes

Edgewise Therapeutics Sees Price Target Boosted to $59 Following Positive HCM Trial Outcomes

By Mr. Money Mustache
AI's Impact on Energy: T1 Energy's Solar Solutions

AI's Impact on Energy: T1 Energy's Solar Solutions

By Mr. Money Mustache
Carnival Corporation: Overcoming Challenges and Projecting Growth

Carnival Corporation: Overcoming Challenges and Projecting Growth

By Vicki Robin
MSCI Acquires Climate Risk Analytics Firm First Street

MSCI Acquires Climate Risk Analytics Firm First Street

By Natalie Pace
Elanco Animal Health: Poised for Significant Growth with New Blockbuster Products and Strategic Ventures

Elanco Animal Health: Poised for Significant Growth with New Blockbuster Products and Strategic Ventures

By JL Collins
Prenetics Global Limited: A Bullish Outlook on Health and Longevity Market Expansion

Prenetics Global Limited: A Bullish Outlook on Health and Longevity Market Expansion

By Mr. Money Mustache
Rocket Pharmaceuticals: A New Chapter After Key Gene Therapy Milestone

Rocket Pharmaceuticals: A New Chapter After Key Gene Therapy Milestone

By Bola Sokunbi
Rare Buying Opportunity: Republic Services for Passive Income Investors

Rare Buying Opportunity: Republic Services for Passive Income Investors

By T. Harv Eker
ResMed Inc.: A Leader in Sleep Health and Respiratory Care

ResMed Inc.: A Leader in Sleep Health and Respiratory Care

By Bola Sokunbi
UniQure N.V. (QURE) Receives 'Overweight' Rating Boost as Huntington's Disease Program Advances

UniQure N.V. (QURE) Receives 'Overweight' Rating Boost as Huntington's Disease Program Advances

By Chika Uwazie
Piper Sandler Initiates Neutral Coverage on Agilent Technologies with $150 Price Target

Piper Sandler Initiates Neutral Coverage on Agilent Technologies with $150 Price Target

By Scott Pape
Chevron's Stock Performance and Investment Outlook

Chevron's Stock Performance and Investment Outlook

By Ramit Sethi